Retro Biosciences

美國 · 研究產業

Retro Biosciences is a biotechnology company based in Redwood City, California, dedicated to extending the healthy human lifespan by approximately 10 years. Founded by CEO Joe Betts-LaCroix, the company focuses on innovative therapies that prevent and reverse age-related diseases by targeting the fundamental cellular drivers of aging. The company employs a multipronged approach, exploring various biological processes related to aging, such as cellular reprogramming, autophagy, and plasma-inspired therapeutics. Retro Biosciences utilizes advanced technologies, including single-cell multi-omics and targeted delivery systems, to develop therapeutics with strong proof of concept in mammalian models and a clear path toward clinical application in humans. Their culture emphasizes speed, rigor, kindness, and versatility, aiming to make a significant impact on healthcare. With substantial investment backing, including a $180 million seed funding round led by prominent figures in Silicon Valley, Retro Biosciences is positioned to address the cellular and molecular damage associated with aging. Their work aims to reduce the burden of chronic diseases and improve healthspan, benefiting both healthcare systems and society.